Use of the Activated Partial Thromboplastin Time for Heparin Monitoring-Reference-Cited by-同舟云学术

Use of the Activated Partial Thromboplastin Time for Heparin Monitoring

Published:2001-01 Issue:1 Volume:115 Page:148-155
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Smythe Maureen A.,Koerber John M.,Westley Susan J.,Nowak Sandra N.,Begle Robert L.,Balasubramaniam Mamtha,Mattson Joan C.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/115/1/148/4984033/ajcpath115-0148.pdf

Reference19 articles.

1. Evaluation of the TAS coagulation analyzer for monitoring heparin effect in cardiac surgical patients;Gibbs;J Cardiothorac Vasc Anesth,1998

2. Taylor CT, Petros WP, Ortel TL. Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring, Pharmacotherapy. 1999;19:383-387.

3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy;Olson;Arch Pathol Lab Med,1998

4. Inability of the activated partial thromboplastin time to predict heparin levels: time to reassess guidelines for heparin assays;Baker;Arch Intern Med,1997

5. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor;Despotis;Crit Care Med,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disposition of Peptides and Other Biological Molecules;Drug Disposition and Pharmacokinetics;2022-09-30

2. Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach;Interactive Journal of Medical Research;2022-09-19

3. First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects;Frontiers in Pharmacology;2022-02-10

4. An ensemble model for predicting therapeutic response to unfractionated heparin therapy (Preprint);2021-10-28

5. Anticoagulation in hemodialysis: A narrative review;Seminars in Dialysis;2020-11